The estrogen hypothesis of Schizophrenia implicates glucose metabolism: Association study in three independent samples

BMC Medical Genetics

Volumn 9, Issue , 2008, Pages

  Olsen, Line ^a   Hansen, Thomas ^a,g   Jakobsen, Klaus D ^a,g   Djurovic, Srdjan ^b   Melle, Ingrid ^b   Agartz, Ingrid ^c   Hall, Haakan ^c   Ullum, Henrik ^d   Timm, Sally ^e   Wang, August G ^f   Jönsson, Erik G ^c   Andreassen, Ole A ^b   Werge, Thomas ^a  

^a Sct Hans Hospital   (Denmark)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^c KAROLINSKA INSTITUTE   (Sweden)

^d Rigshospitalet   (Denmark)

^e University Department of Psychiatry   (Denmark)

^f University Department of Psychiatry   (Denmark)

^g UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ENOLASE; ESTROGEN; FRUCTOSE BISPHOSPHATASE; GLUCOSE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GLYCOGEN SYNTHASE KINASE 3; HEXOKINASE; MITOGEN ACTIVATED PROTEIN KINASE 14; NEURON SPECIFIC ENOLASE; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); PHOSPHOGLYCERATE MUTASE;

ADULT; ALLELE; ARTICLE; BIOINFORMATICS; CASE CONTROL STUDY; CONTROLLED STUDY; DENMARK; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC VARIABILITY; GENOTYPE; GLUCOSE METABOLISM; GLYCOLYSIS; HAPLOTYPE; HEREDITY; HUMAN; HUMAN CELL; HYPOTHESIS; LINKAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; NORWAY; PATHOPHYSIOLOGY; RACE DIFFERENCE; RISK ASSESSMENT; SCANDINAVIA; SCHIZOPHRENIA; SEX DIFFERENCE; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SWEDEN; GENE FREQUENCY; GENETIC MARKER; GENETIC PREDISPOSITION; GENETICS; GLUCOSE BLOOD LEVEL; METABOLISM; MIDDLE AGED; PHYSIOLOGY;

ADULT; BLOOD GLUCOSE; CASE-CONTROL STUDIES; ESTROGENS; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GLYCOLYSIS; HAPLOTYPES; HUMANS; LINKAGE (GENETICS); MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA;

EID: 44249126780     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-9-39     Document Type: Article

References (63)

1. McGuffin P Owen MJ O'Donovan MC Thapar A Gottesman II Seminars in psychiatric genetics Geskell press: London 1994
2. Harrison PJ Weinberger DR Schizophrenia genes, gene expression, and neuropathology: On the matter of their convergence Mol Psychiatry 2005, 10:40-68. 10.1038/sj.mp.4001558 15263907
3. Riley B Kendler KS Molecular genetic studies of schizophrenia Eur J Hum Genet 2006, 14:669-680. 10.1038/sj.ejhg.5201571 16721403
4. Rutter M Moffitt TE Caspi A Gene-environment interplay and psychopathology: Multiple varieties but real effects J Child Psychol Psychiatry 2006, 47:226-261. 10.1111/j.1469-7610.2005.01557.x 16492258
5. Le-Niculescu H Balaraman Y Patel S Tan J Sidhu K Jerome RE Edenberg HJ Kuczenski R Geyer MA Nurnberger JI Jr Towards understanding the schizophrenia code: An expanded convergent functional genomics approach Am J Med Genet B Neuropsychiatr Genet 2007, 144:129-158. 17266109
6. Lipska BK Mitkus SN Mathew SV Fatula R Hyde TM Weinberger DR Kleinman JE Functional genomics in postmortem human brain: Abnormalities in a DISC1 molecular pathway in schizophrenia Dialogues Clin Neurosci 2006, 8:353-357. 17117617
7. Middleton FA Pato CN Gentile KL McGann L Brown AM Trauzzi M Diab H Morley CP Medeiros H Macedo A Gene expression analysis of peripheral blood leukocytes from discordant sib-pairs with schizophrenia and bipolar disorder reveals points of convergence between genetic and functional genomic approaches Am J Med Genet B Neuropsychiatr Genet 2005, 136:12-25. 15892139
8. Leung A Chue P Sex differences in schizophrenia, a review of the literature Acta Psychiatr Scand Suppl 2000, 401:3-38. 10.1111/ j.0065-1591.2000.0ap25.x 10887978
9. Seeman MV Gender differences in schizophrenia Can J Psychiatry 1982, 27:107-112. 6121620
10. Seeman MV Lang M The role of estrogens in schizophrenia gender differences Schizophr Bull 1990, 16:185-194. 2197713
11. Bergemann N Mundt C Parzer P Jannakos I Nagl I Salbach B Klinga K Runnebaum B Resch F Plasma concentrations of estradiol in women suffering from schizophrenia treated with conventional versus atypical antipsychotics Schizophr Res 2005, 73:357-366. 10.1016/ j.schres.2004.06.013 15653282
12. Huber TJ Rollnik J Wilhelms J von Zur MA Emrich HM Schneider U Estradiol levels in psychotic disorders Psychoneuroendocrinology 2001, 26:27-35. 10.1016/S0306-4530(00)00034-2 11070332
13. Huber TJ Borsutzky M Schneider U Emrich HM Psychotic disorders and gonadal function: Evidence supporting the oestrogen hypothesis Acta Psychiatr Scand 2004, 109:269-274. 10.1046/j.1600-0447.2003.00251.x 15008800
14. Riecher-Rossler A Hafner H Stumbaum M Maurer K Schmidt R Can estradiol modulate schizophrenic symptomatology? Schizophr Bull 1994, 20:203-214. 8197416
15. Salokangas RK Gender and the use of neuroleptics in schizophrenia. Further testing of the oestrogen hypothesis Schizophr Res 1995, 16:7-16. 10.1016/0920-9964(94)00059-H 7547647
16. Huber TJ Tettenborn C Leifke E Emrich HM Sex hormones in psychotic men Psychoneuroendocrinology 2005, 30:111-114. 10.1016/ j.psyneuen.2004.05.010 15358449
17. Huber TJ Borsutzky M Schneider U Emrich HM Psychotic disorders and gonadal function: Evidence supporting the oestrogen hypothesis Acta Psychiatr Scand 2004, 109:269-274. 10.1046/j.1600-0447.2003.00251.x 15008800
18. Bergemann N Mundt C Parzer P Jannakos I Nagl I Salbach B Klinga K Runnebaum B Resch F Plasma concentrations of estradiol in women suffering from schizophrenia treated with conventional versus atypical antipsychotics Schizophr Res 2005, 73:357-366. 10.1016/ j.schres.2004.06.013 15653282
19. Huber TJ Rollnik J Wilhelms J von zur MA Emrich HM Schneider U Estradiol levels in psychotic disorders Psychoneuroendocrinology 2001, 26:27-35. 10.1016/S0306-4530(00)00034-2 11070332
20. Boulware MI Mermelstein PG The influence of estradiol on nervous system function Drug News Perspect 2005, 18:631-637. 10.1358/ dnp.2005.18.10.959577 16491165
21. Huber TJ Borsutzky M Schneider U Emrich HM Psychotic disorders and gonadal function: Evidence supporting the oestrogen hypothesis Acta Psychiatr Scand 2004, 109:269-274. 10.1046/j.1600-0447.2003.00251.x 15008800
22. McEwen B Estrogen actions throughout the brain Recent Prog Horm Res 2002, 57:357-384. 10.1210/rp.57.1.357 12017552
23. Garcia-Segura LM Azcoitia I DonCarlos LL Neuroprotection by estradiol Prog Neurobiol 2001, 63:29-60. 10.1016/S0301-0082(00)00025-3 11040417
24. Castle D Sham P Murray R Differences in distribution of ages of onset in males and females with schizophrenia Schizophr Res 1998, 33:179-183. 10.1016/S0920-9964(98)00070-X 9789910
25. Boulware MI Mermelstein PG The influence of estradiol on nervous system function Drug News Perspect 2005, 18:631-637. 10.1358/ dnp.2005.18.10.959577 16491165
26. Garcia-Segura LM Azcoitia I DonCarlos LL Neuroprotection by estradiol Prog Neurobiol 2001, 63:29-60. 10.1016/S0301-0082(00)00025-3 11040417
27. Garcia-Segura LM Azcoitia I DonCarlos LL Neuroprotection by estradiol Prog Neurobiol 2001, 63:29-60. 10.1016/S0301-0082(00)00025-3 11040417
28. Cyr M Calon F Morissette M Di PT Estrogenic modulation of brain activity: Implications for schizophrenia and Parkinson's disease J Psychiatry Neurosci 2002, 27:12-27. 149792 11836973
29. Bergemann N Mundt C Parzer P Jannakos I Nagl I Salbach B Klinga K Runnebaum B Resch F Plasma concentrations of estradiol in women suffering from schizophrenia treated with conventional versus atypical antipsychotics Schizophr Res 2005 73 357 366 10.1016/ j.schres.2004.06.013 15653282
30. Huber TJ Rollnik J Wilhelms J von Zur MA Emrich HM Schneider U Estradiol levels in psychotic disorders Psychoneuroendocrinology 2001, 26:27-35. 10.1016/S0306-4530(00)00034-2 11070332
31. Huber TJ Borsutzky M Schneider U Emrich HM Psychotic disorders and gonadal function: Evidence supporting the oestrogen hypothesis Acta Psychiatr Scand 2004, 109:269-274. 10.1046/j.1600-0447.2003.00251.x 15008800
32. Stone WS Faraone SV Su J Tarbox SI Van EP Tsuang MT Evidence for linkage between regulatory enzymes in glycolysis and schizophrenia in a multiplex sample Am J Med Genet B Neuropsychiatr Genet 2004, 127:5-10. 10.1002/ajmg.b.20132 15108172
33. Peet M Diet, diabetes and schizophrenia: Review and hypothesis Br J Psychiatry Suppl 2004, 47:S102-S105. 10.1192/bjp.184.47.s102 1505660
34. Braceland FJ Meduna LJ Vaichulis JA Delayed action of insulin in schizophrenia Vaichulis, J A 1945, 102:108-110.
35. Schimmelbusch WH Mueller PS Sheps J The positive correlation between insulin resistance and duration of hospitalization in untreated schizophrenia Br J Psychiatry 1971, 118:429-436. 5576642
36. Hagg S Joelsson L Mjorndal T Spigset O Oja G Dahlqvist R Prevalence of diabetes and impaired glucose tolerance in patients treated with clozapine compared with patients treated with conventional depot neuroleptic medications J Clin Psychiatry 1998, 59:294-299. 9671341
37. Popli AP Konicki PE Jurjus GJ Fuller MA Jaskiw GE Clozapine and associated diabetes mellitus J Clin Psychiatry 1997, 58:108-111. 9108812
38. Holmes E Tsang TM Huang JT Leweke FM Koethe D Gerth CW Nolden BM Gross S Schreiber D Nicholson JK Metabolic Profiling of CSF: Evidence That Early Intervention May Impact on Disease Progression and Outcome in Schizophrenia PLoS Med 2006,3:.
39. Holmes E Tsang TM Huang JT Leweke FM Koethe D Gerth CW Nolden BM Gross S Schreiber D Nicholson JK Metabolic Profiling of CSF: Evidence That Early Intervention May Impact on Disease Progression and Outcome in Schizophrenia PLoS Med 2006, 3:.
40. Holmes E Tsang TM Huang JT Leweke FM Koethe D Gerth CW Nolden BM Gross S Schreiber D Nicholson JK Metabolic Profiling of CSF: Evidence That Early Intervention May Impact on Disease Progression and Outcome in Schizophrenia PLoS Med 2006, 3:.
41. Prabakaran S Swatton JE Ryan MM Huffaker SJ Huang JT Griffin JL Wayland M Freeman T Dudbridge F Lilley KS Mitochondrial dysfunction in schizophrenia: Evidence for compromised brain metabolism and oxidative stress Mol Psychiatry 2004, 9:684-97. 643 10.1038/sj.mp.4001532 15098003
42. Prabakaran S Wengenroth M Lockstone HE Lilley K Leweke FM Bahn S 2-D DIGE analysis of liver and red blood cells provides further evidence for oxidative stress in schizophrenia J Proteome Res 2007, 6:141-149. 10.1021/pr060308a 17203958
43. Tosic M Ott J Barral S Bovet P Deppen P Gheorghita F Matthey ML Parnas J Preisig M Saraga M Schizophrenia and oxidative stress: Glutamate cysteine ligase modifier as a susceptibility gene Am J Hum Genet 2006, 79:586-592. 1559555 16909399 10.1086/507566
44. Tang S Han H Bajic VB ERGDB: Estrogen Responsive Genes Database Nucleic Acids Res 2004, 32:D533-D536. 308817 14681475 10.1093/nar/gkh083
45. Hoffmann R Valencia A Implementing the iHOP concept for navigation of biomedical literature Bioinformatics 2005, 21(Suppl 2):iI252-ii258. 10.1093/bioinformatics/bti1142 16204114
46. Nikitin A Egorov S Daraselia N Mazo I Pathway studio - the analysis and navigation of molecular networks Bioinformatics 2003, 19:2155-2157. 10.1093/bioinformatics/btg290 14594725
47. Dennis G Jr Sherman BT Hosack DA Yang J Gao W Lane HC Lempicki RA DAVID: Database for Annotation, Visualization, and Integrated Discovery Genome Biol 2003, 4:3. 10.1186/gb-2003-4-5-p3
48. Kanehisa M Goto S KEGG: Kyoto encyclopedia of genes and genomes Nucleic Acids Res 2000, 28:27-30. 102409 10592173 10.1093/nar/28.1.27
49. McGuffin P Farmer A Harvey I A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system Arch Gen Psychiatry 1991, 48:764-770. 1883262
50. Williams J Farmer AE Ackenheil M Kaufmann CA McGuffin P A multicentre inter-rater reliability study using the OPCRIT computerized diagnostic system Psychol Med 1996, 26:775-783. 8817712
51. Ekholm B Ekholm A Adolfsson R Vares M Osby U Sedvall GC Jonsson EG Evaluation of diagnostic procedures in Swedish patients with schizophrenia and related psychoses Nord J Psychiatry 2005, 59:457-464. 10.1080/08039480500360906 16316898
52. Jonsson EG Edman-Ahlbom B Sillen A Gunnar A Kulle B Frigessi A Vares M Ekholm B Wode-Helgodt B Schumacher J Brain-derived neurotrophic factor gene (BDNF) variants and schizophrenia: An association study Prog Neuropsychopharmacol Biol Psychiatry 2006, 30:924-933. 10.1016/ j.pnpbp.2006.02.008 16581172
53. Vares M Ekholm A Sedvall GC Hall H Jonsson EG Characterization of patients with schizophrenia and related psychoses: Evaluation of different diagnostic procedures Psychopathology 2005, 39:286-295. 10.1159/000095733
54. Jonsson EG Edman-Ahlbom B Sillen A Gunnar A Kulle B Frigessi A Vares M Ekholm B Wode-Helgodt B Schumacher J Brain-derived neurotrophic factor gene (BDNF) variants and schizophrenia: An association study Prog Neuropsychopharmacol Biol Psychiatry 2006, 30:924-933. 10.1016/ j.pnpbp.2006.02.008 16581172
55. de Bakker PI Yelensky R Pe'er I Gabriel SB Daly MJ Altshuler D Efficiency and power in genetic association studies Nat Genet 2005, 37:1217-1223. 10.1038/ng1669 16244653
56. Barrett JC Fry B Maller J Daly MJ Haploview: Analysis and visualization of LD and haplotype maps Bioinformatics 2005, 21:263-265. 10.1093/ bioinformatics/bth457 15297300
57. Fan JB Oliphant A Shen R Kermani BG Garcia F Gunderson KL Hansen M Steemers F Butler SL Deloukas P Highly parallel SNP genotyping Cold Spring Harb Symp Quant Biol 2003, 68:69-78. 10.1101/sqb.2003.68.69 15338605
58. Excoffier L Laval G Schneider S Arlequin ver. 3.0: An integrated software package for population genetics data analysis Evolutionary Bioinformatics Online 2005, 1:47-50.
59. Purcell S PLINK 2007:0.99.
60. Dudbridge F Pedigree disequilibrium tests for multilocus haplotypes Genet Epidemiol 2003, 25:115-121. 10.1002/gepi.10252 12916020
61. Dudbridge F UNPHASED user guide 2006.
62. Barrett JC Fry B Maller J Daly MJ Haploview: Analysis and visualization of LD and haplotype maps Bioinformatics 2005, 21:263-265. 10.1093/ bioinformatics/bth457 15297300
63. Gabriel SB Schaffner SF Nguyen H Moore JM Roy J Blumenstiel B Higgins J DeFelice M Lochner A Faggart M The structure of haplotype blocks in the human genome Science 2002, 296:2225-2229. 10.1126/science.1069424 12029063